Pro Share Advisors LLC Novavax Inc Transaction History

Pro Share Advisors LLC

$42.9 Billion
Q1 2025

A detailed history of Pro Share Advisors LLC transactions in Novavax Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 60,602 shares of NVAX stock, worth $419,365. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,602

Previous 70,988 14.63%

Holding current value

$419,365

Previous $570,000 31.93%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	SELL	$6.41 - $10.82 $66,574 - $112,376	-10,386 Reduced 14.63%	60,602 $388,000
Q4 2024 Feb 13, 2025	BUY	$7.22 - $14.68 $159,208 - $323,708	22,051 Added 45.06%	70,988 $570,000
Q3 2024 Nov 13, 2024	BUY	$10.71 - $17.11 $132,054 - $210,966	12,330 Added 33.68%	48,937 $618,000
Q2 2024 Aug 13, 2024	SELL	$3.89 - $20.97 $2,318 - $12,498	-596 Reduced 1.6%	36,607 $463,000
Q1 2024 May 08, 2024	BUY	$3.76 - $6.02 $32,223 - $51,591	8,570 Added 29.93%	37,203 $177,000
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $36,523 - $58,361	7,609 Added 36.19%	28,633 $137,000
Q3 2023 Nov 13, 2023	BUY	$6.81 - $9.74 $3,902 - $5,581	573 Added 2.8%	21,024 $152,000
Q2 2023 Aug 10, 2023	BUY	$6.67 - $9.52 $136,408 - $194,693	20,451 New	20,451 $151,000
Q2 2022 Aug 01, 2022	SELL	$36.28 - $75.29 $79,199 - $164,358	-2,183 Reduced 22.86%	7,365 $379,000
Q1 2022 May 10, 2022	SELL	$69.73 - $142.9 $208,980 - $428,271	-2,997 Reduced 23.89%	9,548 $703,000
Q4 2021 Feb 08, 2022	SELL	$134.56 - $217.97 $690,427 - $1.12 Million	-5,131 Reduced 29.03%	12,545 $1.8 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $337,286 - $513,290	1,897 Added 12.02%	17,676 $3.66 Million
Q2 2021 Aug 13, 2021	SELL	$121.0 - $257.67 $1.31 Million - $2.78 Million	-10,808 Reduced 40.65%	15,779 $3.35 Million
Q1 2021 May 14, 2021	BUY	$112.98 - $319.93 $231,609 - $655,856	2,050 Added 8.35%	26,587 $4.82 Million
Q4 2020 Feb 09, 2021	BUY	$78.74 - $139.5 $1.26 Million - $2.23 Million	16,006 Added 187.62%	24,537 $2.74 Million
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $49,173 - $110,497	619 Added 7.82%	8,531 $924,000
Q2 2020 Aug 03, 2020	BUY	$13.86 - $83.61 $109,660 - $661,522	7,912 New	7,912 $659,000

Others Institutions Holding NVAX

# of Institutions

299

Shares Held

90M

Call Options Held

5.76M

Put Options Held

6.65M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $541M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Novavax Inc Transaction History